Additional information

Bipolar disorder or manic depression is a mental disorder that can lead to depression and mood fluctuations. The global bipolar disorder market will be growing at a CAGR of 2.2% to reach $4.9 Billion by 2025 from $XX Billion in 2019 during 2019-2025. Factors such as government initiatives to increase public awareness about the effects of bipolar disorders, high demand for anti-depressants and increase in treatment options for genetic disorders are driving the bipolar disorder market growth during the forecast period. However, the major restraints hampering the market growth are a dearth of proper diagnostic procedures for the identification of the disorder, less number of anticonvulsants for bipolar disorder treatment, and side effects associated with bipolar disorder therapeutics. Advancements related to combination therapies of drugs and high potential in emerging economies are creating major opportunities to the bipolar disorder market during the forecast period 2019-2025.

Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).

Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Bipolar Disorder Market Analysis

Analysis and conclusions on the future Bipolar Disorder market outlook.

Top-down and bottom-up approaches are used to validate the Bipolar Disorder Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Bipolar Disorder Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Bipolar Disorder market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The Scope of The Report

The Bipolar Disorder Market Segmentation is as follows:

By Type

Bipolar I disorder

Bipolar II disorder

By Drug Class

Mood stabiliser

Anticonvulsant

Antipsychotic drugs

Antidepressant drugs

Antianxiety drugs

By Mechanism of Action

Selective serotonin reuptake inhibitor

Serotonin norepinephrine reuptake inhibitor

Tricyclic antidepressants

Monoamine oxidase inhibitors

Benzodiazepines

Beta blockers

Others

Geographical Analysis:

Bipolar Disorder Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customization Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Bipolar Disorder Market include:

Scope Revision

Geographic Analysis

Company Profiles

Historical Data & Forecasting

Key Contact Persons in companies

Global Bipolar Disorder Market Research Report Includes:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact on altering market dynamics.

Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

Identify the latest developments, market shares and strategies that are employed by the significant Bipolar Disorder Market Players, such as

Abbott Laboratories

Bristol-Myers Squibb Company

AstraZeneca plc

Otsuka America Pharmaceutical Inc.

Repligen Corporation

Along with these companies, many other companies are considered in the report while analysing the Global Bipolar Disorder Competitive Strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.

CHAPTER 1 INTRODUCTION

1.1. Market Definition

1.2. Executive Summary

1.3. The Scope of the Study

CHAPTER 2 RESEARCH METHODOLOGY

2.1. Secondary Research

2.2. Primary Research

2.3. Analytic Tools and Model

2.4. Economic Indicator

2.4.1 Base Year, Base Currency, Forecasting Period

2.5. Expert Validation

2.6. Study Timeline

CHAPTER 3 MARKET ANALYSIS

3.1. Industry Value Chain Analysis

3.2. Porter’s Five Force Analysis

3.2.1. Bargaining Power of Buyers

3.2.2. Bargaining Power of Suppliers

3.2.3. Threats of Substitutes

3.2.4. Threats of New Entrants

3.2.5. Degree of Competition

3.3. PESTLE Analysis

3.3.1. Political

3.3.2. Economical

3.3.3. Social

3.3.4. Technological

3.3.5. Legal

3.3.6. Environmental

3.4. SWOT Analysis

3.4.1. Strengths

3.4.2. Weakness

3.4.3. Opportunities

3.4.4. Threats

3.5. Y-O-Y Analysis

CHAPTER 4 MARKET DYNAMICS

4.1. Market Drivers

4.1.1. Increasing prevalence of bipolar disorder

4.1.2. Government initiatives and technological advancements

4.1.3. High demand for anti-depressants

4.1.4. Growing need to reduce the disease burden of bipolar disorder

4.1.5. Increase in treatment options for bipolar disorder

4.2. Market Restraints & Challenges

4.2.1. The dearth of proper diagnostic procedures for the identification of the disorder

4.2.2. Side effects associated with bipolar disorder therapeutics

4.2.3. Less number of approved anticonvulsants for the treatment of bipolar disorder

4.3. Market Opportunities

4.3.1. Advancements related to combination therapies of drugs

4.3.2. High potential in emerging economies

CHAPTER 5 GLOBAL BIPOLAR DISORDER MARKET – BY TYPE

5.1. Bipolar I disorder

5.2. Bipolar II disorder

CHAPTER 6 GLOBAL BIPOLAR DISORDER MARKET – BY DRUG CLASS

6.1. Mood stabiliser

6.2. Anticonvulsant

6.3. Antipsychotic drugs

6.4. Antidepressant drugs

6.5. Antianxiety drugs

CHAPTER 7 GLOBAL BIPOLAR DISORDER MARKET – BY MECHANISM OF

ACTION

7.1. Selective serotonin reuptake inhibitor

7.2. Serotonin norepinephrine reuptake inhibitor

7.3. Tricyclic antidepressants

7.4. Monoamine oxidase inhibitors

7.5. Benzodiazepines

7.6. Beta blockers

7.7. Others

CHAPTER 8 GLOBAL BIPOLAR DISORDER MARKET – BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. U.S.

8.2.2. Canada

8.2.3. Mexico

8.2.4. Costa Rica

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Chile

8.3.4. Columbia

8.3.5. Others

8.4. Europe

8.4.1. U.K.

8.4.2. Germany

8.4.3. France

8.4.4. Italy

8.4.5. Spain

8.4.6. Russia

8.4.7. Netherlands

8.4.8. Switzerland

8.4.9. Poland

8.4.10. Others

8.5. APAC

8.5.1. China

8.5.2. Japan

8.5.3. India

8.5.4. South Korea

8.5.5. Australia & New Zealand

8.5.6. Malaysia

8.5.7. Singapore

8.5.8. Others

8.6. Middle East & Africa

8.6.1. UAE

8.6.2. Saudi Arabia

8.6.3. Iran

8.6.4. Iraq

8.6.5. Qatar

8.6.6. South Africa

8.6.7. Algeria

8.6.8. Morocco

8.6.9. Nigeria

8.6.10. Egypt

8.6.11. Others

CHAPTER 9 GLOBAL BIPOLAR DISORDER MARKET – COMPANY PROFILES

9.1. Abbott Laboratories

9.2. Bristol-Myers Squibb Company

9.3. AstraZeneca plc

9.4. Eli Lilly and Company

9.5. GlaxoSmithKline plc

9.6. Merck & Co., Inc.

9.7. Johnson & Johnson

9.8. Pfizer Inc.

9.9. Cephalon Inc.

9.10. Gedeon Richter plc

9.11. H. Lundbeck A/S

9.12. Otsuka America Pharmaceutical Inc.

9.13. Repligen Corporation

9.14. Validus Pharmaceuticals LLC

9.15. Allergen PLC

CHAPTER 10 GLOBAL BIPOLAR DISORDER MARKET – COMPETITIVE

LANDSCAPE

10.1. Market Share Analysis

10.2. Strategies adopted by top companies

10.3. Mergers, Acquisitions, Collaborations & Agreements

CHAPTER 11 MARKET INSIGHTS

11.1. Industry Experts Insights

11.2. Analysts Opinions

11.3. Investment Opportunities

CHAPTER 12 APPENDIX

12.1. List of Tables

12.2. List of Figures

Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.

Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.

The Regional and Global Variety is taken care of in the report.

Year on Year basis generation of revenue is studied.

Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.

The overview and the sustainability of the market are analyzed through SWOT.

DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.

The segment-level analysis in terms of type and technology.

The value chain analysis, value that's created and captured by a company is the profit margin.

Value Created and Captured – Cost of Creating that Value = Margin

An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.

Basis on the depth of the study we approach using analytical tools

Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.

Bipolar disorder or manic depression is a mental disorder that can lead to depression and mood fluctuations. The global bipolar disorder market will be growing at a CAGR of 2.2% to reach $4.9 Billion by 2025 from $XX Billion in 2019 during 2019-2025. Factors such as government initiatives to increase public awareness about the effects of bipolar disorders, high demand for anti-depressants and increase in treatment options for genetic disorders are driving the bipolar disorder market growth during the forecast period. However, the major restraints hampering the market growth are a dearth of proper diagnostic procedures for the identification of the disorder, less number of anticonvulsants for bipolar disorder treatment, and side effects associated with bipolar disorder therapeutics. Advancements related to combination therapies of drugs and high potential in emerging economies are creating major opportunities to the bipolar disorder market during the forecast period 2019-2025.

Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).

Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Bipolar Disorder Market Analysis

Analysis and conclusions on the future Bipolar Disorder market outlook.

Top-down and bottom-up approaches are used to validate the Bipolar Disorder Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Bipolar Disorder Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Bipolar Disorder market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The Scope of The Report

The Bipolar Disorder Market Segmentation is as follows:

By Type

Bipolar I disorder

Bipolar II disorder

By Drug Class

Mood stabiliser

Anticonvulsant

Antipsychotic drugs

Antidepressant drugs

Antianxiety drugs

By Mechanism of Action

Selective serotonin reuptake inhibitor

Serotonin norepinephrine reuptake inhibitor

Tricyclic antidepressants

Monoamine oxidase inhibitors

Benzodiazepines

Beta blockers

Others

Geographical Analysis:

Bipolar Disorder Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customization Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Bipolar Disorder Market include:

Scope Revision

Geographic Analysis

Company Profiles

Historical Data & Forecasting

Key Contact Persons in companies

Global Bipolar Disorder Market Research Report Includes:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact on altering market dynamics.

Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

Identify the latest developments, market shares and strategies that are employed by the significant Bipolar Disorder Market Players, such as

Abbott Laboratories

Bristol-Myers Squibb Company

AstraZeneca plc

Otsuka America Pharmaceutical Inc.

Repligen Corporation

Along with these companies, many other companies are considered in the report while analysing the Global Bipolar Disorder Competitive Strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.

CHAPTER 1 INTRODUCTION

1.1. Market Definition

1.2. Executive Summary

1.3. The Scope of the Study

CHAPTER 2 RESEARCH METHODOLOGY

2.1. Secondary Research

2.2. Primary Research

2.3. Analytic Tools and Model

2.4. Economic Indicator

2.4.1 Base Year, Base Currency, Forecasting Period

2.5. Expert Validation

2.6. Study Timeline

CHAPTER 3 MARKET ANALYSIS

3.1. Industry Value Chain Analysis

3.2. Porter’s Five Force Analysis

3.2.1. Bargaining Power of Buyers

3.2.2. Bargaining Power of Suppliers

3.2.3. Threats of Substitutes

3.2.4. Threats of New Entrants

3.2.5. Degree of Competition

3.3. PESTLE Analysis

3.3.1. Political

3.3.2. Economical

3.3.3. Social

3.3.4. Technological

3.3.5. Legal

3.3.6. Environmental

3.4. SWOT Analysis

3.4.1. Strengths

3.4.2. Weakness

3.4.3. Opportunities

3.4.4. Threats

3.5. Y-O-Y Analysis

CHAPTER 4 MARKET DYNAMICS

4.1. Market Drivers

4.1.1. Increasing prevalence of bipolar disorder

4.1.2. Government initiatives and technological advancements

4.1.3. High demand for anti-depressants

4.1.4. Growing need to reduce the disease burden of bipolar disorder

4.1.5. Increase in treatment options for bipolar disorder

4.2. Market Restraints & Challenges

4.2.1. The dearth of proper diagnostic procedures for the identification of the disorder

4.2.2. Side effects associated with bipolar disorder therapeutics

4.2.3. Less number of approved anticonvulsants for the treatment of bipolar disorder

4.3. Market Opportunities

4.3.1. Advancements related to combination therapies of drugs

4.3.2. High potential in emerging economies

CHAPTER 5 GLOBAL BIPOLAR DISORDER MARKET – BY TYPE

5.1. Bipolar I disorder

5.2. Bipolar II disorder

CHAPTER 6 GLOBAL BIPOLAR DISORDER MARKET – BY DRUG CLASS

6.1. Mood stabiliser

6.2. Anticonvulsant

6.3. Antipsychotic drugs

6.4. Antidepressant drugs

6.5. Antianxiety drugs

CHAPTER 7 GLOBAL BIPOLAR DISORDER MARKET – BY MECHANISM OF

ACTION

7.1. Selective serotonin reuptake inhibitor

7.2. Serotonin norepinephrine reuptake inhibitor

7.3. Tricyclic antidepressants

7.4. Monoamine oxidase inhibitors

7.5. Benzodiazepines

7.6. Beta blockers

7.7. Others

CHAPTER 8 GLOBAL BIPOLAR DISORDER MARKET – BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. U.S.

8.2.2. Canada

8.2.3. Mexico

8.2.4. Costa Rica

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Chile

8.3.4. Columbia

8.3.5. Others

8.4. Europe

8.4.1. U.K.

8.4.2. Germany

8.4.3. France

8.4.4. Italy

8.4.5. Spain

8.4.6. Russia

8.4.7. Netherlands

8.4.8. Switzerland

8.4.9. Poland

8.4.10. Others

8.5. APAC

8.5.1. China

8.5.2. Japan

8.5.3. India

8.5.4. South Korea

8.5.5. Australia & New Zealand

8.5.6. Malaysia

8.5.7. Singapore

8.5.8. Others

8.6. Middle East & Africa

8.6.1. UAE

8.6.2. Saudi Arabia

8.6.3. Iran

8.6.4. Iraq

8.6.5. Qatar

8.6.6. South Africa

8.6.7. Algeria

8.6.8. Morocco

8.6.9. Nigeria

8.6.10. Egypt

8.6.11. Others

CHAPTER 9 GLOBAL BIPOLAR DISORDER MARKET – COMPANY PROFILES

9.1. Abbott Laboratories

9.2. Bristol-Myers Squibb Company

9.3. AstraZeneca plc

9.4. Eli Lilly and Company

9.5. GlaxoSmithKline plc

9.6. Merck & Co., Inc.

9.7. Johnson & Johnson

9.8. Pfizer Inc.

9.9. Cephalon Inc.

9.10. Gedeon Richter plc

9.11. H. Lundbeck A/S

9.12. Otsuka America Pharmaceutical Inc.

9.13. Repligen Corporation

9.14. Validus Pharmaceuticals LLC

9.15. Allergen PLC

CHAPTER 10 GLOBAL BIPOLAR DISORDER MARKET – COMPETITIVE

LANDSCAPE

10.1. Market Share Analysis

10.2. Strategies adopted by top companies

10.3. Mergers, Acquisitions, Collaborations & Agreements

CHAPTER 11 MARKET INSIGHTS

11.1. Industry Experts Insights

11.2. Analysts Opinions

11.3. Investment Opportunities

CHAPTER 12 APPENDIX

12.1. List of Tables

12.2. List of Figures

Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.

Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.

The Regional and Global Variety is taken care of in the report.

Year on Year basis generation of revenue is studied.

Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.

The overview and the sustainability of the market are analyzed through SWOT.

DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.

The segment-level analysis in terms of type and technology.

The value chain analysis, value that's created and captured by a company is the profit margin.

Value Created and Captured – Cost of Creating that Value = Margin

An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.

Basis on the depth of the study we approach using analytical tools

Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.

Envision Inteligence is the Main Supplier of Market Analysis Reviews, Customized Consulting Companies, Information Analytics and Trade Evaluation. Our purpose is to offer the correct data required by the stakeholder on the proper level of time.Read More